Tower Research Capital »

Cidara Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.9k 746 11.94

More positions owned by Tower Research Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)

View all positions for Tower Research Capital

Top funds holding Cidara Therapeutics

Monashee Investment Management
BVF
Vanguard Group
Checkpoint Capital
Renaissance Technologies
Alethea Capital Management
5AM Venture Management
BlackRock
Geode Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Russell Investments
Tower Research Capital
Manchester Capital Management
Pacifica Partners

View all funds holding Cidara Therapeutics